Dist-Pune, India

Dattatray Maruti More


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dattatray Maruti More: Innovator in Pharmaceutical Compounds

Introduction

Dattatray Maruti More is a notable inventor based in Dist-Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating inflammatory disorders. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving healthcare.

Latest Patents

Dattatray Maruti More holds a patent for "Tricyclic compounds for the treatment of inflammatory disorders." This invention provides compounds represented by a specific formula, which includes various stereoisomeric and tautomeric forms. These compounds are designed to be effective in treating inflammatory disorders caused by elevated levels of proinflammatory cytokines, such as Tumor Necrosis Factor (TNF-α) and interleukins (IL-1β, IL-6, IL-8). The patent also covers processes for manufacturing these compounds and pharmaceutical compositions containing them. He has 1 patent to his name.

Career Highlights

Dattatray Maruti More is currently associated with Piramal Enterprises Limited, a leading company in the pharmaceutical sector. His role at the company allows him to apply his innovative ideas and contribute to the development of new therapeutic solutions. His work is instrumental in advancing the company's research and development efforts.

Collaborations

Dattatray has collaborated with notable coworkers, including Dilip Narayanrao Bhedi and Ram Asrey Vishwakarma. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Dattatray Maruti More is a distinguished inventor whose work in pharmaceutical compounds has the potential to make a meaningful impact on the treatment of inflammatory disorders. His dedication to innovation and collaboration continues to drive advancements in healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…